国际肿瘤学杂志

国际肿瘤学杂志 ›› 2015, Vol. 42 ›› Issue (3): 214-217.doi: 10.3760/cma.j.issn.1673422X.2015.03.014

• 综述 • 上一篇    下一篇

 Ⅳ期食管癌的治疗现状

郑涛, 李涛, 吴敬波   

  1. 位：646000 四川省泸州医学院附属医院肿瘤科
  • 出版日期:2015-03-08 发布日期:2015-01-29
  • 通讯作者: 李涛，Email: litaoxmf@126.com E-mail:litaoxmf@126.com

Status treatment of the Ⅳ stage esophageal cancer

Zheng Tao, Li Tao, Wu Jingbo   

  1. Department of Oncology, Affiliated Hospital of Luzhou Medical College, Luzhou 646000, China
  • Online:2015-03-08 Published:2015-01-29
  • Contact: Li Tao E-mail:litaoxmf@126.com

PDF

1368

摘要： Ⅳ期食管癌是指存在区域外淋巴结或远处器官转移的患者，姑息放化疗是主要的治疗手段。随着临床研究的不断深入，单纯放疗和化疗不再是单一的治疗手段，化疗联合分子靶向药物、放化联合治疗以及一些新的治疗手段在临床上逐渐得到认可，尤其分子靶向药物开始确立其在肿瘤治疗中的地位，多种治疗手段的单独或联合应用可以有效延长患者的生存期和提高患者的生命质量。

关键词: 食管肿瘤, 药物疗法, 放射疗法, 营养支持

Abstract: The Ⅳ stage esophageal cancer refers to exist regional lymph nodes and distant organs in patients with metastases. Palliative chemotherapy and radiotherapy is the primary treatment. With the deepening of the clinical study, radiotherapy and chemotherapy are no longer single treatment, chemotherapy combined molecular targeted drugs, chemoradiotherapy and some new treatment methods have been gradually recognized, and especially molecular targeted drugs began to establish its position in the treatment of tumor. Application of various methods individual or combined treatment can effectively prolong survival and improve the quality of life.

Key words: Esophageal neoplasms, Drug therapy, Radiotherapy, Nutritional support